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EFFECTS OF GROWTH HORMONE ON TESTICULAR TESTOSTERONE
 
PRODUCTION IN VITRO IN TRANSGENIC MICE
 
BACKGROUND: 
A transgenic animal is generated by injecting foreign 
DNA into fertilized eggs. The eggs are then implanted in 
pseudopregnant females. If this DNA is incorporated into the 
genotype the foreign DNA may be expressed and can be 
inherited by offspring. When DNA for growth hormone (GH) 
from another species is used, the animal produces the growth 
hormone for the other species (1, 9). 
In transgenic mice the foreign growth hormone genes 
cause an increased growth rate which begins usually during 
the fourth week following birth. The growth rate then 
remains increased and the adult transgenic mouse weight is 
50% or more greater than their normal siblings. Transgenic 
mice appear to age faster than their littermates and the 
average life-span of transgenic mice is reduced. The male 
transgenic mice display a decreased fertility as compared to 
their siblings. This decrease in fertility is of concern in 
the application of transgenic technology to domestic animals 
such as sheep, swine, and cattle (1). 
Growth hormone is secreted by the anterior pituitary 
and it stimulates growth of almost all cells and tissues of 
the body (6). It is presently thought that the actions of 
growth hormone are mediated by insulin-like growth factor I 
(IGF-I). IGF-I is an 70-amino acid straight chain peptide 
(4). In transgenic mice the growth hormone level may be 1000 
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times greater than normal, but the level of circulating IGF-I 
is elevated by a factor of 2 or 3 which is consistent with 
the hypothesis that GH effects on growth are mediated by IGF­
(7). In mice it has been shown that the synthesis of IGF-I 
mRNA is induced by GH at about two weeks of age, and one week 
later the transgenic mice begin to show an increased growth 
rate. IGF-I is induced before changes in weight and growth 
are apparent, but the initial levels of IGF-I in transgenic 
mice may not be elevated enough to show an increased growth 
response to GH (9). There are high affinity binding sites 
for IGF-I in the Leydig cells of the testes, and IGF-I has an 
effect on testosterone production in the Leydig cells. IGF-I 
can increase basal and human chorionic gonadotropin (heG) 
stimulated testosterone production in the testes in vitro 
(8) . 
The Leydig cells are located in the interstices between 
the seminiferous tubules in the testes. These cells secrete 
testosterone, a steroid hormone, when stimulated by 
luteinizing hormone (LH) which is released from the anterior 
pituitary (2). Before birth and after puberty Leydig cells 
are numerous and produce large quantities of testosterone, 
but during childhood the Leydig cells are almost nonexistent 
(8). It has been suggested that GH, along with LH, and 
prolactin (PRL) is responsible for maintaining the number of 
LH receptors in the Leydig cells in the testes (11). In some 
studies it has been shown that when GH was administered to 
immature rats the responsiveness of the Leydig cells to 
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exogenous LH was increased (11). 
Testosterone is essential for the growth and maintenance 
of the male sex organs and in mice it is also responsible for 
mating behavior. When male mice reach about thirty days of 
age their production of testosterone begins to increase 
sharply. This increase lasts until between 50 and 60 days of 
age then the production levels off and begins to slowly 
decline with age. It has been shown that in male mice the 
adult testosterone production is not constant, but is 
characterized by alternating periods of high and low 
testosterone production (3). 
EXPERIMENT: 
This experiment compared the testicular testosterone 
production response to hCG in vitro in transgenic mice versus 
their normal siblings. The amount of testosterone produced 
during the incubation was measured by radioimmunoassay. 
All of the mice for this experiment were obtained from 
the Southern Illinois University at Carbondale vivarium. All 
of the transgenic mice in this study had a bovine growth 
hormone gene with a phosphoenolpyruvate carboxykinase 
promoter (PEPCK bGH). Phosphoenolpyruvate carboxykinase is 
an enzyme that is present in the body and is used during 
gluconeogenesis (10). When the promoter of the gene for 
PEPCK is combined with the bGH gene the coding for GH will be 
initiated in several organs including the liver and the 
kidneys (9). 
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The mice used were the results of matings between PEPCK 
bGH males with 1. 2, or 25 gene copies with B6C3Fl females. 
The mice were housed four to six per cage since weaning in a 
room with a controlled photoperiod of 14 hour days and 10 
hour nights and a temperature of 22±lC. The mice were fed a 
nutritionally balanced diet and given free access to tap 
water. Transgenic and normal male siblings between three and 
five months of age were used in this experiment. For this 
experiment three different incubations were performed. For 
two of the incubations the transgenic mice were PEPCK bGH 1 
copy. The mice used for the third incubation included 
transgenic mice which were PEPCK bGH 2 copies, and the 
transgenic mice used for the fourth incubation were PEPCK bGH 
25 copies. 
INCUBATION: 
To incubate the testes the mice were weighed and then 
decapitated. The testes were removed and their weights 
before and after decapsulation were recorded (Table 1). The 
bodies were placed on ice. After the seminal vesicle 
secretions had hardened the coagulating gland was removed and 
the weights of the seminal vesicles were recorded (Table 1). 
Each testis was cut into halves and the fragments were 
weighed. Each fragment was placed in a 30 ml glass beaker 
containing 2.0 ml of buffer. The fragments were allowed to 
preincubate for thirty minutes in a Dubnoff shaking incubator 
at 320C and 100 rpm to remove the testosterone present in the 
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testes. A mixture of 95% 02 and 5% C02 was bubbled over the 
fragments as they incubated. 
The four fragments from each pair of testes were then 
placed in 30 ml beakers containing 1.9 ml of fresh buffer and 
.1 ml of either 0 mIU, 2 mIU, 10 mIU, or 50 mIUI ml of hCG. 
Human chorionic gonadotropin has almost the same properties 
as LH and stimulates the production of testosterone in the 
Leydig cells (6). The-fragments were incubated for three 
hours using the same procedure as for the preincubation. 
After the incubation period was over, the fragments and 
the media were poured into test tubes and centrifuged at 40C 
at 1000 rpm for 5 minutes. The supernate was poured into 
plastic vials and frozen until assayed. 
RADIOIMMUNOASSAY: 
Radioimmunoassays were performed to measure the amount 
of testosterone produced by each of the fragments during the 
incubation. A radioimmunoassay for a hormone like 
testosterone involves mixing measured amounts of the hormone 
samples, antibody for that hormone, and aliquots of the 
hormone with a radiolabel. The basic principle is that the 
radiolabeled and unlabeled hormone will compete for binding 
to the antibody, and will bind with the same affinity. After 
an incubation period, other materials are added to separate 
the unbound radioactively labeled hormone from the rest of 
the solution. The amount of radioactive material that is 
left in the solution can be measured with a radiation 
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detector. 
In tubes that contain a large amount of unlabeled 
hormone, little of the radioactive hormone will bind to the 
antibody and the reading on the radiation detector will 
reflect this low amount of radioactive material present. 
Conversely, tubes that contain little of the unlabeled 
hormone will have a higher amount of radioactive hormone 
bound to the antibody and a greater amount of radioactivity 
will be detected. To correlate the reading from the 
radiation detector with actual hormone levels, samples of a 
known concentration of hormone are included in the assay so 
that a standard curve can be generated. Other samples are 
also included in the assay to determine the total amount of 
radioactivity added to each tube (totals), the amount of the 
radioactively labeled hormone that was bound to other 
proteins present in the mixture and was not removed with the 
unbound labeled hormone ( non-specific binding or NSB), and 
the total amount of binding possible (bounds). From this 
information the amount of hormone in each sample can be 
determined. 
Before assaying the media obtained from the incubations, 
the media had to be diluted so that when 25 ul and 50 ul 
samples were assayed approximately 50% of the bound 
hormone would be radiolabeled. A binding of 50% is 
desirable because it is in this range that the assay tends to 
be the most accurate. The correct dilutions were determined 
by approximating the dilution required, assaying that 
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dilution, and then adjusting the dilution to obtain binding 
of approximately 50%. Before each assay the tritium labeled 
testosterone (H3-T) was diluted with gel-PBS so that a 100 ul 
aliquot in 9 ml of scintillation cocktail would have a count 
between 8000 and 10000 counts per minute. 
To establish baseline levels for each assay, eleven 
tubes containing 100 ul of gel-PBS were used to measure the 
binding in the total, NSB, and the bound tubes. The standard 
curve was established by aliquoting in triplicate 100 ul 
samples of 5, 10, 15, 25, 50, 100, 150, 250, and 500 pg 
samples of the standard. Duplicate 25 ul aliquots of the Lo, 
Med, and Hi standard were also assayed. Twenty-five and 50 
ul aliquots of each sample were measured, and then gel-PBS 
was added to each tube in the assay to bring the total volume 
of each tube to 100 ul. A 100 ul aliquot of a 1:30,000 
solution of testosterone antibody was added to each tube' 
except for the four totals tubes and the two NSB tubes to 
which 100 ul of gel-PBS was added. The tubes were vortexed 
in a multitube vortexer and 15 minutes later 100 ul of the 
diluted H3-T was added to all tubes. The tubes were 
vortexed, covered and kept for 16-20 hours at refrigerator 
temperature. This incubation period was necessary so that 
the binding between the antibody, and both the labeled and 
unlabeled testosterone would reach equilibrium. 
After the 16-20 hour period, 1 ml of a charcoal dextran 
solution, was added to' each of the tubes except the totals to 
which 1 ml of gel-PBS was added. The tubes were vortexed and 
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allowed to sit for 15 minutes. The fifteen minute period 
began when the first aliquot of charcoal was added, and the 
charcoal solution had to be added to all of the tubes in the 
first five minute period. The charcoal solution was used to 
bind to the H3-T that was not bound to antibody, and remove 
it from the solution. After the fifteen minute interval, the 
tubes were centrifuged for 12 minutes at 3000 rpm at 4oC. 
A .6 ml aliquot of the supernate was removed from each 
tube and placed in a scintillation vial with 4.5 ml of 
scintillation cocktail. The scintillation cocktail was a 
toluene based solution that would emit light when it was 
radiated with beta emissions from the radioactive decay of 
the tritium. The scintillation counter would measure the 
amount of light emitted and display the result as counts per 
minute. The vials were capped, vortexed, cleaned with an 
antistatic solution, and placed in the scintillation counter. 
The vials were allowed to rest for one hour before they were 
counted. 
The assay results were analyzed on a radioimmunoassay 
program developed at SIU-C for use with LOTUS 123. Any set of 
duplicates that had a testosterone value 2 or more times 
greater than the duplicate value was considered an inaccurate 
set and reassayed. The ng testosterone/ mg testis tissue was 
calculated and averaged (Table 2) and graphs of the data were 
made (Figs. 1-3). 
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RESULTS: 
TABLE 1: BODY MEASUREMENTS FOR THREE STRAINS OF PEPCK bGH 
TRANSGENIC MICE AND NORMAL SIBLINGS 
BODY TESTES WT.(mg) SEMINAL VESICLE n= 
STRAIN WT. (g) DECAPSULATION WT. (mg) 
BEFORE AFTER 
1 COPY 
TRANSGENIC 54.5±.5.2 256±.28.7 216±.30.6 295±.56.5 10 
NORMAL 30.8±.2.5 229±.20.2 203±.23.6 170±.28.7 8 
2 COPIES 
TRANSGENIC 49.6±.4.1 288±.27.9 220±.27.6 279±.66.4 5 
NORMAL 33.8±.3.6 248±.26.5 193±.20.0 220±.14.9 4 
25 COPIES 
TRANSGENIC 50.8±.2.2 275±.20.5 231±.28.2 252±.40.9 5 
NORMAL 27.3±.2.6 231±.31.4 169±.18.1 196±.25.3 4 
TABLE 2: TESTOSTERONE PRODUCTION IN VITRO FOR VARIOUS
 
STRAINS OF PEPCK bGH IN TRANSGENIC MICE AND
 
NORMAL SIBLINGS IN RESPONSE TO hCG
 
STRAIN TESTOSTERONE PRODUCTION (ng/ mg testis) n= 
o 2 10 50 mIU hCG 
1 COpy 
TRANSGENIC .33±..22 2.5±.1.3 12±.5.9 13±.7.0 10 
NORMAL . 33±.. 23 3. 2±.1 .6 1l±.6. 5 12±.12 8 
2 COPIES 
TRANSGENIC .31±..29 1.3±.1.6 3.8±.3.3 8.4±.4.5 5 
NORMAL .17±..02 .54±..23 4.0±.1.2 5.9±.3.7 4 
25 COPIES 
TRANSGENIC .50±..13 3.7±.1.6 4.9±.2.5 10±.3.7 5 
NORMAL . 38±.. 21 2. 1±.. 92 5. 4±.2. 6 11±.3. 9 4 
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DISCUSSION: 
Results of the present study indicate that the ability 
of the testes to produce testosterone in vitro and to respond 
to hCG stimulation was not altered in any of the examined 
strains of transgenic mice. The amount of testosterone 
produced per mg of testis tissue was not altered, but the 
fr.agments from the transgenic mice produced a larger quantity 
of testosterone due to the larger size of the testes in these 
mice. Within each strain of mice there was a large variation 
between the amount of testosterone produced per mg tissue 
derived from different animals. This could be caused by the 
peaks and troughs in testosterone production as discussed 
earlier. 
As seen in table 1, the seminal vesicle weight, the 
testes weight, and the body weight were on the average higher 
in the transgenic mice for each strain than the normal 
siblings. The increased weight of these organs is an 
indication of the actions of growth hormone. 
It is shown in the graphs that the strains with 2 and 25 
copies of bGH did not reach peak testosterone production 
level at 10 mIU hCG/ ml as did the 1 copy bGH. These strains 
also did not reach the same maximum testosterone production 
as the 1 copy. This could be a result of differences in 
incubation conditions. The tissues for the 1 copy were 
incubated at separate times while the tissues from the 2 and 
25 copy strains were incubated at the same time using the 
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same solutions. When the incubation for the 2 and 25 copy 
strains was performed the gas flow was accidently interrupted 
for no more than an hour and this could have altered the 
response to hCG, or altered the maximum level of testosterone 
production. Since all of the fragments had been exposed to 
the same conditions, these results were still considered 
valid for the purpose of comparing the differences in 
testosterone production in normal and transgenic siblings. 
In summary, the transgenic and normal mice of the 3 
strains exhibited marked differences in body weight and in 
testes and seminal vesicle weight. These differences in size 
were not reflected in the testicular testosterone production 
since the normal and transgenic mice both produced 
approximately the same amount of testosterone! mg testis when 
incubated in vitro in the presence or in the absence of hCG. 
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